Tag Health & medicine
With high-risk, high-reward investment, UW–Madison researcher seeks to outwit cancer’s resistance to treatment
Sequencing the tumor samples’ genetic material will allow the researchers to map changes in individual tumors that became resistant and discern possible common mechanisms of resistance across multiple tumors.
UW researchers have uncovered a key feature of breast cancers that renders them either vulnerable or resistant to paclitaxel treatment, which could help identify which patients are most likely to see success.
When the COVID-19 pandemic threw the world into turmoil in the spring of 2020, the experts at the Wisconsin Veterinary Diagnostic Laboratory and the Wisconsin State Laboratory of Hygiene instead got to work.
As of Sept. 1, 88 percent of students are fully vaccinated and 91 percent of students have received at least one dose. In addition, 92 percent of employees are fully vaccinated.
In partnership with the Boys and Girls Club of Dane County, students and employees of the School of Pharmacy are helping sponsor vaccine clinics and town hall discussions to address vaccine hesitancy and concerns.
"A school can identify quickly if a staff member or a kid who comes in the school who might have symptoms comes in the school and should get sent home."
The multi-site trial at UW–Madison is in its first phase and is testing a personalized topical medication in the form of a gel as a way to treat vascular anomalies.
A study led by the Centers for Disease Control and Prevention found that the UW–Madison’s prevention efforts, including a two-week quarantine of two residence halls, likely helped contain the outbreak.
In this Badger Talks, Haley Vlach walks us through the reasons why the pandemic has been so challenging for our memory.
While the approach hasn’t yet been tested in humans and researchers must further refine and test the system, it does provide a new strategy for potentially preventing or treating these common infections.
A new study from a team of researchers at the University of Wisconsin–Madison has found that the e-prescribing tool CancelRx more than doubled the proportion of successfully discontinued medications, from 34 percent to 93 percent, at UW Health, a major health system in Wisconsin.
The results offer a foundation for research into treating the often-overlooked cognitive impairments of bipolar disorder, such as memory loss, and add to a growing understanding of how the biochemistry of the brain affects health and disease.
WSLH coordinates the Wisconsin Clinical Lab Network, with more than 130 hospital and clinical labs across the state, and was able to quickly pull together collaborations to increase COVID-19 testing capacity.
Vaccines provide hope that the worst of the pandemic will soon be behind us, but they also can lead to some tricky conversations. In this week’s Badger Talks video, vaccine etiquette is discussed.
"Being able to contribute to warding off this disease is so empowering and rewarding, and it just makes me feel like all this suffering all of us have been experiencing is moving toward a resolution," said nursing student Kayla Van Boxtel.
The lab has performed nearly 200,000 COVID-19 tests on the UW–Madison campus while also playing a key role handling a COVID-19 outbreak among Wisconsin’s mink industry.
The WisCon consultants have dedicated time this year to COVID-19 consulting and training for small businesses, which includes virtual assessments of facilities, recommendations for controlling employee exposure, and video training on COVID-19 prevention and control.
The number of people in the UW–Madison community who have reported receiving at least one dose of the vaccine, whether on campus or off, now exceeds 10,000.
Nearly 10,000 students and employees have received at least one shot of either a two-dose or one-dose vaccine, both at UHS and reported off campus.
One patient was the first in Wisconsin to receive a double-lung transplant after COVID-19. Another had a brain tumor successfully removed after a poor prognosis.